U.S. federal trademark · Serial No. 76309833
Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.